BioMark Diagnostics CSO Participates in Life Sciences Conference in Montreal
What happened
BioMark Diagnostics Inc., a company specializing in liquid biopsy technologies for early lung cancer detection via metabolomics, announced its participation in life sciences events in Quebec during the week of October 4, 2026. The company will attend the 16th Annual Mass Spectrometry & Advances in the Clinical Lab (MSACL 2026) conference in Montreal. BioMark's Chief Scientific Officer and General Manager, Dr. Jean-François Haince, is scheduled to speak on a panel discussion regarding the clinical translation of biomarker discoveries on October 8, 2026.
From thewhig.com
Why it matters
The company's participation showcases its technology alongside partners Sciex and Phytronix Technologies during industry workshops. The events gather international clinical mass spectrometry experts, laboratory directors, and clinical scientists, indicating industry engagement with BioMark's focus area.
From thewhig.com
Who's involved
- Quebec CityBioMark Diagnostics Inc., a leader in liquid biopsy technologies focused on early lung cancer detection.
- MontrealThe location of the MSACL 2026 conference and the company's operational base.
- QuebecThe province of Quebec, where the company maintains a laboratory.
Keep exploring
The entities involved
-
Quebec City
capital city of the province of Quebec, Canada
-
Montreal
largest city in Quebec, Canada